These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25313338)

  • 1. Cytokines in bipolar disorder: paving the way for neuroprogression.
    Barbosa IG; Bauer ME; Machado-Vieira R; Teixeira AL
    Neural Plast; 2014; 2014():360481. PubMed ID: 25313338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunology of bipolar disorder.
    Barbosa IG; Machado-Vieira R; Soares JC; Teixeira AL
    Neuroimmunomodulation; 2014; 21(2-3):117-22. PubMed ID: 24557044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.
    Barichello T; Giridharan VV; Bhatti G; Sayana P; Doifode T; Macedo D; Quevedo J
    Curr Top Behav Neurosci; 2021; 48():215-237. PubMed ID: 33040314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.
    Calkin CV
    Ann Med; 2019; 51(5-6):281-293. PubMed ID: 31453713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review.
    Giridharan VV; Sayana P; Pinjari OF; Ahmad N; da Rosa MI; Quevedo J; Barichello T
    Mol Psychiatry; 2020 Jan; 25(1):94-113. PubMed ID: 31249382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients.
    Sayana P; Colpo GD; Simões LR; Giridharan VV; Teixeira AL; Quevedo J; Barichello T
    J Psychiatr Res; 2017 Sep; 92():160-182. PubMed ID: 28458141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Areas of controversy in neuroprogression in bipolar disorder.
    Passos IC; Mwangi B; Vieta E; Berk M; Kapczinski F
    Acta Psychiatr Scand; 2016 Aug; 134(2):91-103. PubMed ID: 27097559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature.
    Castaño-Ramírez OM; Sepúlveda-Arias JC; Duica K; Díaz Zuluaga AM; Vargas C; López-Jaramillo C
    Rev Colomb Psiquiatr (Engl Ed); 2018; 47(2):119-128. PubMed ID: 29754705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets.
    Ascoli BM; Géa LP; Colombo R; Barbé-Tuana FM; Kapczinski F; Rosa AR
    Aust N Z J Psychiatry; 2016 Jul; 50(7):618-30. PubMed ID: 27091850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are medical comorbid conditions of bipolar disorder due to immune dysfunction?
    Rosenblat JD; McIntyre RS
    Acta Psychiatr Scand; 2015 Sep; 132(3):180-91. PubMed ID: 25772638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging and neuroprogression in bipolar disorder: a systematic review of the literature.
    Gama CS; Kunz M; Magalhães PV; Kapczinski F
    Braz J Psychiatry; 2013 Mar; 35(1):70-4. PubMed ID: 23567604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting inflammation in bipolar disorder.
    Fries GR; Walss-Bass C; Bauer ME; Teixeira AL
    Pharmacol Biochem Behav; 2019 Feb; 177():12-19. PubMed ID: 30586559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications.
    Rosenblat JD; Brietzke E; Mansur RB; Maruschak NA; Lee Y; McIntyre RS
    J Affect Disord; 2015 Dec; 188():149-59. PubMed ID: 26363613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder.
    do Prado CH; Rizzo LB; Wieck A; Lopes RP; Teixeira AL; Grassi-Oliveira R; Bauer ME
    Psychoneuroendocrinology; 2013 May; 38(5):667-76. PubMed ID: 22989476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
    Berk M; Kapczinski F; Andreazza AC; Dean OM; Giorlando F; Maes M; Yücel M; Gama CS; Dodd S; Dean B; Magalhães PV; Amminger P; McGorry P; Malhi GS
    Neurosci Biobehav Rev; 2011 Jan; 35(3):804-17. PubMed ID: 20934453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison study of metabolic profiles, immunity, and brain gray matter volumes between patients with bipolar disorder and depressive disorder.
    Bai YM; Chen MH; Hsu JW; Huang KL; Tu PC; Chang WC; Su TP; Li CT; Lin WC; Tsai SJ
    J Neuroinflammation; 2020 Jan; 17(1):42. PubMed ID: 32000805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious and immunogenetic factors in bipolar disorder.
    Oliveira J; Oliveira-Maia AJ; Tamouza R; Brown AS; Leboyer M
    Acta Psychiatr Scand; 2017 Oct; 136(4):409-423. PubMed ID: 28832904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar Disorder and Inflammation.
    Rosenblat JD; McIntyre RS
    Psychiatr Clin North Am; 2016 Mar; 39(1):125-37. PubMed ID: 26876323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging and neuroprogression in bipolar disorder.
    Fries GR; Pfaffenseller B; Stertz L; Paz AV; Dargél AA; Kunz M; Kapczinski F
    Curr Psychiatry Rep; 2012 Dec; 14(6):667-75. PubMed ID: 23090632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.